Treatment Options for Gastrointestinal Stromal Tumor (GIST)
Gastrointestinal stromal tumors (GISTs) are rare tumors that form in the digestive tract, usually in the stomach or small intestine. It develops from special cells called interstitial cells of Cajal (ICCs), which help control the movement of food through the digestive system.
The objective of treatment for GISTs can vary depending on the specific situation:
- Curative Intent: In cases where GISTs are resectable, meaning they can be completely or almost completely removed by surgery, the objective of treatment is curative. Surgery is performed to remove the tumors, especially if they are 2 centimeters or larger. Laparoscopic surgery may be an option for tumors that are 5 cm or smaller. After surgery, watchful waiting or targeted therapy with medications like imatinib mesylate may be recommended if there are cancer cells remaining at the edges of the area where the tumor was removed. The goal is to decrease the chance of recurrence (the tumor coming back).
- Slowing down progression: For GISTs that have spread (metastasized) or come back after treatment (recurred), the goal is to slow the tumor’s growth. Medications like imatinib mesylate and sunitinib are often used for this. Imatinib mesylate is the first choice, and sunitinib may be used if the tumor continues to grow or if the side effects of imatinib mesylate are too severe. Targeted therapy may also continue after surgery if the tumor responds well to treatment.
- Controlling symptoms: If GISTs cause problems like bleeding, a hole in the digestive tract, a blockage, or infection, surgery may be done to remove tumors and relieve these symptoms.
It's important to note that standard chemotherapy and radiotherapy are not commonly used as primary treatments for GISTs. However, radiotherapy may be used as a palliative therapy to help ease pain (such as bone pain) or control bleeding.
Overall, treatment objectives for GISTs can vary depending on factors such as tumor size, location, and whether it has spread or recurred. The goal is to provide the most appropriate treatment approach to each individual patient in order to achieve optimal outcomes and improve their quality of life.
The recommended potential treatments for Gastrointestinal Stromal Tumor (GIST) include:
- Surgical Resection: The first treatment for GIST is surgery to remove the tumor. The goal is to completely take out the tumor from the gastrointestinal tract.
- Targeted Therapy with Imatinib Mesylate: Imatinib mesylate is a medication that targets and blocks the growth of cancer cells in GIST. It is often the first treatment for GIST that has spread (metastatic) or come back (recurrent). The aim of this therapy is to shrink or stabilize the tumor and slow its growth.
- Targeted Therapy with Sunitinib: Sunitinib is another medication used if the tumor keeps growing during imatinib mesylate treatment or if the side effects of imatinib mesylate are too severe. It helps to block cancer cell growth and control the tumor’s progression.
- Observation: For some pediatric patients with GIST, observation (watching the tumor closely without immediate surgery) may be an option. This approach is used if the tumor grows slowly (indolent) and doesn’t cause major symptoms.
- Surgical Resection for SDH-Deficient GIST: For children with SDH-deficient GIST, surgery is recommended to remove the localized tumor. SDH-deficient GISTs usually grow slowly, so extensive or repeated surgeries should be avoided.
- Clinical Trials: Participation in clinical trials may be an option for patients with metastatic or recurrent GIST. These trials test new treatments or approaches to improve outcomes for people with GIST.
It is important to note that treatment decisions should be made in consultation with a healthcare professional who specializes in the treatment of GIST. They can provide personalized recommendations based on individual factors such as tumor characteristics, stage of disease, and overall health status.